What Is Type 2 Diabetes? Causes, Symptoms & Treatment

Type 2 diabetes is a chronic metabolic condition in which the body either does not produce enough insulin or does not use it effectively — causing blood glucose to remain elevated above normal levels and progressively damaging the kidneys, eyes, nerves, and cardiovascular system. India has approximately 77 million adults with Type 2 diabetes, making it the country with the second-highest diabetic population in the world. Ahmedabad, with its urban lifestyle, changing dietary patterns, and genetic predisposition among Gujarati and wider Indian populations, reflects this national burden directly. At Sangini Hospital in Satellite, Ahmedabad, Dr Tapan Shah and Dr Harsh Maniar provide comprehensive Type 2 diabetes treatment — from initial diagnosis through long-term complication prevention.

What Actually Causes Type 2 Diabetes

Type 2 diabetes does not have a single cause. It is the result of a combination of genetic predisposition, metabolic dysfunction, and lifestyle factors converging over years — which is why it develops gradually and why most people have been living with elevated blood sugar long before the diagnosis arrives.

• Insulin resistance — the central mechanism: The pancreas produces insulin — a hormone that acts as a key, unlocking cells to allow glucose from the bloodstream to enter and be used for energy. In Type 2 diabetes, the body’s cells become resistant to insulin’s signal. The key still exists, but the locks have become unresponsive. The pancreas compensates by producing more insulin — for years, this compensation keeps blood glucose within a manageable range. But the pancreatic beta cells producing that insulin are working under sustained stress. Eventually they fatigue, insulin output declines, and blood glucose rises above the diagnostic threshold. By the time Type 2 diabetes is diagnosed, beta cell function has often already declined by 50 percent or more.
• Visceral fat and the Indian body composition problem: Indians develop insulin resistance at a lower BMI than Western populations. This is because Indians tend to accumulate visceral fat — fat stored around the abdominal organs — at a higher rate relative to overall body weight. Visceral fat is metabolically active in a specific and damaging way: it releases free fatty acids and inflammatory cytokines directly into the portal circulation, where they reach the liver and impair insulin signalling at the hepatic level. A Gujarati adult with a BMI of 24 who appears normal weight by Western standards may already have significant visceral fat and insulin resistance. This is why the BMI threshold for diabetes risk screening in South Asians is set at 23, not 25.
• Genetic predisposition: First-degree relatives of someone with Type 2 diabetes have a two to four times higher risk of developing it. Several gene variants associated with impaired insulin secretion and insulin resistance are more prevalent in Indian populations than in European ones. Genetic risk does not determine outcome — but it determines how much less lifestyle and environmental factors need to deviate from optimal before diabetes develops.
• Other contributing factors: Sedentary behaviour reduces the muscle cells’ sensitivity to insulin — muscle is the largest site of glucose uptake in the body, and inactive muscle takes up glucose less efficiently. Disrupted sleep reduces insulin sensitivity measurably, even after a single night of poor sleep. Chronic psychological stress elevates cortisol, which directly antagonises insulin action. Polycystic ovary syndrome (PCOS) carries insulin resistance as a core feature, predisposing women with PCOS to Type 2 diabetes at significantly higher rates than the general population.

Symptoms — Why Most People Miss Them

Type 2 diabetes develops over years before producing obvious symptoms — and the symptoms it does produce are easily rationalised away:

• Fatigue that rest does not resolve — cells starved of glucose signal exhaustion regardless of how much the person sleeps
• Excessive thirst and frequent urination — the kidneys excrete excess glucose by pulling water from the body; the resulting dehydration drives thirst and increases urine volume
• Blurred vision — glucose draws fluid from the eye lens, changing its shape temporarily
• Slow-healing wounds and recurrent skin infections — elevated glucose impairs both circulation and immune response
• Tingling or numbness in feet — early peripheral neuropathy from sustained glucose elevation
• Unexplained weight changes — weight gain from insulin-driven fat storage in early insulin resistance; weight loss when insulin production falls significantly

The majority of Type 2 diabetes diagnoses in India are made incidentally — during a pre-surgical blood test, a routine corporate health check, or investigation for an unrelated complaint. The person had symptoms for years. They attributed them to other causes.

How Type 2 Diabetes Is Diagnosed

Diagnosis requires blood testing — symptoms alone are not sufficient. The standard diagnostic criteria are:

At Sangini Hospital in Satellite, Ahmedabad, all diagnostic tests — fasting glucose, HbA1c, kidney function, lipid panel, and urine microalbumin — are available on-site. Results are reviewed in the same consultation in most cases, meaning a patient who comes in for screening leaves with a clear answer and a management plan the same day.

Understanding HbA1c — The Most Important Number in Diabetes Management

HbA1c — glycated haemoglobin — measures the average blood glucose level over the preceding two to three months. Unlike a fasting glucose reading, which reflects blood sugar at a single point in time, HbA1c captures the cumulative glucose exposure of red blood cells during their lifespan.

For most adults with Type 2 diabetes, the target HbA1c is below 7 percent. This target is individualised — a younger patient with newly diagnosed diabetes and no complications may target 6.5 percent, while an older patient with significant cardiovascular disease may have a more relaxed target of 7.5 to 8 percent to reduce hypoglycaemia risk.

HbA1c is measured every three months when diabetes is not at target, and every six months once stable. A consistently elevated HbA1c means the current treatment plan is not working — not that the patient is failing. It is an objective signal to adjust the plan.

Type 2 Diabetes Treatment — The Escalation Approach

Treatment for Type 2 diabetes follows a structured escalation — beginning with the interventions that carry the lowest burden and greatest reversibility, progressing to medication and insulin as the condition evolves.

1. Lifestyle intervention — the foundation of all treatment: Diet modification, physical activity, and weight management form the foundation. For patients diagnosed at the prediabetes or early Type 2 stage, lifestyle intervention alone returns HbA1c to the normal range in a significant proportion — the Diabetes Prevention Program found that modest weight loss (5 to 7 percent of body weight) with 150 minutes of moderate activity per week reduced diabetes incidence by 58 percent in high-risk individuals. At Sangini Hospital, dietary guidance is calibrated to Gujarati food patterns — jowar and bajra rotis, dal-based meals, minimising maida and white rice portions — not generic Western advice that does not translate to an Ahmedabad kitchen.
2. First-line medication — Metformin: When lifestyle intervention alone does not achieve target HbA1c, Metformin is the universal first-line medication. It reduces liver glucose output, improves insulin sensitivity in muscle tissue, and has a safety record spanning six decades of clinical use. It does not cause hypoglycaemia when used alone. It is inexpensive, generic, and well-tolerated by the majority of patients. Dr Tapan Shah prescribes Metformin in doses titrated to the patient’s kidney function and tolerance — starting low and building gradually to reduce gastrointestinal side effects.
3. Second-line agents — newer drug classes with additional benefits: When Metformin alone does not achieve target, or when specific comorbidities are present, second-line agents are added:

• SGLT2 inhibitors (empagliflozin, dapagliflozin) — reduce blood glucose by excreting it in urine, while also reducing cardiovascular events and slowing kidney disease progression. Now recommended as second-line for patients with established cardiovascular disease or chronic kidney disease regardless of HbA1c.
• GLP-1 receptor agonists (semaglutide, liraglutide) — stimulate insulin secretion in a glucose-dependent way, suppress appetite, and produce significant weight loss. Cardiovascular and kidney protection benefits are established.
• DPP-4 inhibitors (sitagliptin, vildagliptin) — well-tolerated, weight-neutral, modest glucose reduction. Used when other agents are not tolerated.
• Sulfonylureas — older, effective, inexpensive, but carry hypoglycaemia risk and weight gain. Still widely used when cost is a primary consideration.

Dr Harsh Maniar’s involvement in clinical research at Sangini Hospital ensures that prescribing at the clinic reflects current evidence — including the cardiovascular and renal benefits of newer agents that have changed prescribing guidelines significantly in the last five years.

Insulin therapy: When oral and injectable agents do not achieve adequate control, or when beta cell function has declined sufficiently, insulin becomes necessary. Insulin therapy is not a failure of management — it is a reflection of disease progression. Modern insulin analogues allow flexible dosing regimens that fit around work schedules and meal patterns. Insulin initiation is managed carefully at Sangini Hospital with detailed patient education on injection technique, dose adjustment, and hypoglycaemia recognition.

Preventing Complications — The Long Game

The purpose of treating blood sugar numbers is to protect organs. The specific complication screening every patient with Type 2 diabetes should receive annually includes:

• Kidney function — serum creatinine and urine microalbumin, to detect early diabetic nephropathy before it becomes chronic kidney disease
• Eye examination — fundus photography or ophthalmologist referral for diabetic retinopathy
• Foot examination — neurological and vascular assessment to detect peripheral neuropathy before ulceration develops
• Lipid panel and blood pressure — cardiovascular risk management alongside glucose control
• ECG — cardiac screening, particularly for patients over 50

A diabetes care plan at Sangini Hospital includes this full annual screening protocol — not just HbA1c monitoring — because the numbers are the means, not the end.

Frequently Asked Questions

Can Type 2 diabetes be reversed permanently?

In the prediabetes stage, returning blood glucose to normal through lifestyle intervention is common and durable. In early Type 2 diabetes — particularly within the first five years of diagnosis and in patients who achieve significant weight loss — remission is achievable. Remission means HbA1c below 6.5 percent without medication. It requires sustained lifestyle maintenance to remain in remission, and beta cell function continues to decline with age regardless. It is better described as sustained remission than permanent cure.

What is the difference between Type 1 and Type 2 diabetes?

Type 1 diabetes is an autoimmune condition where the immune system destroys pancreatic beta cells entirely. Insulin production stops completely and external insulin is required from diagnosis onward. Type 2 diabetes involves progressive insulin resistance and relative insulin insufficiency — the pancreas still produces some insulin, but not enough to overcome the resistance. Type 2 is far more common, accounting for 90 to 95 percent of all diabetes cases. The types of diabetes are explained in detail on the Sangini Hospital website.

How often should HbA1c be checked?

Every three months when diabetes is not at target or when medication has been changed. Every six months once HbA1c has been stable at target for a full year. This frequency is not negotiable — HbA1c is the single most important monitoring measure in diabetes management, and checking it less frequently means missing deterioration early enough to correct it with a simple medication adjustment.

Does everyone with Type 2 diabetes eventually need insulin?

No. Many patients with Type 2 diabetes achieve and maintain good control throughout their lives with oral medication and lifestyle management. The likelihood of needing insulin increases with disease duration — as beta cell function continues to decline — and with the degree of HbA1c elevation at diagnosis. Patients who achieve and maintain good early control slow the rate of beta cell decline significantly, reducing the probability of insulin requirement over a 10 to 20-year horizon.

What is the best diet for Type 2 diabetes in an Indian household?

A diabetes-appropriate Indian diet emphasises low glycaemic index grains — jowar, bajra, brown rice — over refined flour and white rice. Dal-based meals provide protein that slows glucose absorption. Non-starchy vegetables form the bulk of the plate. Portion control matters more than food elimination — a quarter plate of rice with dal and sabzi is metabolically different from a full plate. Sangini Hospital provides detailed dietary guidance calibrated to Gujarati eating patterns, including festival foods and restaurant navigation, as part of every diabetes management consultation.

How does Sangini Hospital in Satellite Ahmedabad manage Type 2 diabetes long-term?

Sangini Hospital provides comprehensive Type 2 diabetes treatment including initial diagnosis, HbA1c monitoring every three months, on-site blood testing, personalised medication management, dietary guidance calibrated to Gujarati food patterns, annual complication screening, and 24×7 access for acute concerns at 079-40056171. Dr Tapan Shah and Dr Harsh Maniar manage patients from diagnosis through every stage — not just at presentation.

Managing It Well From Day One Changes Every Number That Follows

Type 2 diabetes managed well in the first five years produces better outcomes dramatically at the ten and twenty-year marks — lower kidney damage rates, lower retinopathy rates, lower amputation rates, lower cardiovascular events. The investment in early, comprehensive management pays compound returns in health outcomes.

At Sangini Hospital in Satellite, Ahmedabad, that management begins at the first consultation and continues through every stage of the disease — with the diagnostic tools, the specialist experience, and the monitoring infrastructure to make the long game winnable.

Book your diabetes consultation today.

📍 Sangini Hospital — 1st Floor, Santorini Square, Satellite, Ahmedabad – 380015 📞 079-40056171 | 📧 support@sanginihospital.com 👨‍⚕️ Dr Tapan Shah (MD, Consultant Physician) | Dr Harsh Maniar (Internal Medicine & Clinical Research)

For more information, click below:

Sangini Hospital – Multispeciality Hospital